Pharma

Your Article Summary

See Latest Articles

Naviscan Receives 510(k) Clearance for Stereo Navigator - the First Commercially Available Breast PET-Guided Biopsy Feature
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08

Naviscan, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its biopsy-guidance feature designed exclusively for use with its high-resolution organ-specific PET scanner. The scanner's breast application is Positron Emission Mammography (PEM).

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/08/09

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

 See all of Drug/Product Approvals